Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 17,96117,980 of 20,252 grants

Completed NON SBIR/STTR CONTRACTS
DEVELOPMENT & MANUFACTURE OF ORAL & TOPICAL DOSAGE FORMS - NOVOBIOCIN CAPSULE PRODUCTION BASE (TASK 1) 12 MONTHS & OPTION 1 (TASK 2) A CGMP BATCH SHEL
NATIONAL CANCER INSTITUTE Irisys, Inc United States 2021 – 2024

The aim of the contract to manufacture Drug Product (Novobiocin is Capsule and Triapine is Injectable)

$4.13M
USD
Completed OTHER RESEARCH-RELATED
Mechanisms Of Akt Regulation
NATIONAL CANCER INSTITUTE Ohio State University United States 2021 – 2024

Abstract: The Ser/Thr protein kinase Akt1 is key signaling enzyme that participates in the regulation of cell growth and other physiologic processes, and its dysregulation contribu...

$1.87M
USD
Completed OTHER RESEARCH-RELATED
Mechanisms Of Akt Regulation
NATIONAL CANCER INSTITUTE Ohio State University United States 2021 – 2023

Abstract: The Ser/Thr protein kinase Akt1 is key signaling enzyme that participates in the regulation of cell growth and other physiologic processes, and its dysregulation contribu...

$1.87M
USD
Completed NON-SBIR/STTR RPGS
Biomaterial Scaffolds for Ex Vivo and In Situ CAR-T Cell Production
NATIONAL CANCER INSTITUTE North Carolina State University Raleigh United States 2021 – 2026

PROJECT SUMMARY Despite unprecedented clinical success of chimeric antigen receptor (CAR)-T cell therapy against tumors, widespread application is limited by lengthy and labor-inte...

$4.07M
USD
Completed NON-SBIR/STTR RPGS
Radiation-induced senescence in the brain microenvironment: Implications for glioblastoma recurrence and therapy
NATIONAL CANCER INSTITUTE University of Texas Hlth Science Center United States 2021 – 2026

Abstract Glioblastomas (GBM) are aggressive and radioresistant brain cancers for which better therapeutic approaches are desperately needed.GBM patients are treated with 50-60 Gy o...

$3.68M
USD
Completed TRAINING, INDIVIDUAL
Contributions of SETD2 mutations in clear cell renal cell carcinoma (ccRCC)
NATIONAL CANCER INSTITUTE Ut Southwestern Medical Center United States 2021 – 2025

Project Summary Cancer epigenetics has driven a surge of research in recent years as several chromatin- associated factors have been identified in the process of tumorigenesis.A cr...

$365.5K
USD
Completed SBIR-STTR RPGS
Administrative Supplement for the Evaluation of the novel, uni-directional, Pd-103 CivaSheet for Lung Cancer
NATIONAL CANCER INSTITUTE Civatech Oncology, Inc United States 2021 – 2021

Parent Award: R44CA217587 Clinical Evaluation of the novel, Uni-directional Pd-103 CivaSheet for Lung Cancers CivaTech Oncology?s mission is to provide improved radiation therapy d...

$2.2M
USD
Completed NON SBIR/STTR CONTRACTS
TITLE: PHARMACOKINETIC AND ORAL BIOAVAILABILITY STUDIES IN RATS.PERIOD OF PERFORMANCE: 4/16/2021 TO 4/15/2022SEVERABLE - FIXED PRICE TYPE TASK ORDER
NATIONAL CANCER INSTITUTE University of Pittsburgh At Pittsburgh United States 2021 – 2022

This Task Order was awarded under an IDIQ contract pool which provides a resource for conducting nonclinical pharmacology, pharmacokinetic, and metabolism studies with candidate th...

$773.8K
USD
Completed NON-SBIR/STTR RPGS
Radiation-induced senescence in the brain microenvironment: Implications for glioblastoma recurrence and therapy
NATIONAL CANCER INSTITUTE University of Texas Hlth Science Center United States 2021 – 2026

Abstract Glioblastomas (GBM) are aggressive and radioresistant brain cancers for which better therapeutic approaches are desperately needed. GBM patients are treated with 50-60 Gy...

$3.49M
USD
Completed NON-SBIR/STTR RPGS
Biomaterial Scaffolds for Ex Vivo and In Situ CAR-T Cell Production
NATIONAL CANCER INSTITUTE North Carolina State University Raleigh United States 2021 – 2026

PROJECT SUMMARY Despite unprecedented clinical success of chimeric antigen receptor (CAR)-T cell therapy against tumors, widespread application is limited by lengthy and labor-inte...

$3.84M
USD
Completed TRAINING, INDIVIDUAL
Contributions of SETD2 mutations in clear cell renal cell carcinoma (ccRCC)
NATIONAL CANCER INSTITUTE Ut Southwestern Medical Center United States 2021 – 2025

Project Summary Cancer epigenetics has driven a surge of research in recent years as several chromatin- associated factors have been identified in the process of tumorigenesis. A c...

$372.6K
USD
Completed NON SBIR/STTR CONTRACTS
TITLE: PHARMACOKINETIC AND ORAL BIOAVAILABILITY STUDIES IN RATS.PERIOD OF PERFORMANCE: 4/16/2021 TO 4/15/2022SEVERABLE - FIXED PRICE TYPE TASK ORDER
NATIONAL CANCER INSTITUTE University of Pittsburgh At Pittsburgh United States 2021 – 2022

This Task Order was awarded under an IDIQ contract pool which provides a resource for conducting nonclinical pharmacology, pharmacokinetic, and metabolism studies with candidate th...

$257.9K
USD
Completed NON-SBIR/STTR RPGS
Radiation-induced senescence in the brain microenvironment: Implications for glioblastoma recurrence and therapy
NATIONAL CANCER INSTITUTE University of Texas Hlth Science Center United States 2021 – 2026

Abstract Glioblastomas (GBM) are aggressive and radioresistant brain cancers for which better therapeutic approaches are desperately needed. GBM patients are treated with 50-60 Gy...

$3.49M
USD
Completed NON-SBIR/STTR RPGS
Biomaterial Scaffolds for Ex Vivo and In Situ CAR-T Cell Production
NATIONAL CANCER INSTITUTE North Carolina State University Raleigh United States 2021 – 2026

PROJECT SUMMARY Despite unprecedented clinical success of chimeric antigen receptor (CAR)-T cell therapy against tumors, widespread application is limited by lengthy and labor-inte...

$3.76M
USD
Completed TRAINING, INDIVIDUAL
Contributions of SETD2 mutations in clear cell renal cell carcinoma (ccRCC)
NATIONAL CANCER INSTITUTE Ut Southwestern Medical Center United States 2021 – 2025

Project Summary Cancer epigenetics has driven a surge of research in recent years as several chromatin- associated factors have been identified in the process of tumorigenesis. A c...

$382K
USD
Completed NON-SBIR/STTR RPGS
Biomaterial Scaffolds for Ex Vivo and In Situ CAR-T Cell Production
NATIONAL CANCER INSTITUTE North Carolina State University Raleigh United States 2021 – 2026

PROJECT SUMMARY Despite unprecedented clinical success of chimeric antigen receptor (CAR)-T cell therapy against tumors, widespread application is limited by lengthy and labor-inte...

$850.5K
USD
Completed NON-SBIR/STTR RPGS
Radiation-induced senescence in the brain microenvironment: Implications for glioblastoma recurrence and therapy
NATIONAL CANCER INSTITUTE University of Texas Hlth Science Center United States 2021 – 2026

Abstract Glioblastomas (GBM) are aggressive and radioresistant brain cancers for which better therapeutic approaches are desperately needed. GBM patients are treated with 50-60 Gy...

$3.39M
USD
Completed TRAINING, INDIVIDUAL
Contributions of SETD2 mutations in clear cell renal cell carcinoma (ccRCC)
NATIONAL CANCER INSTITUTE Ut Southwestern Medical Center United States 2021 – 2024

Project Summary Cancer epigenetics has driven a surge of research in recent years as several chromatin- associated factors have been identified in the process of tumorigenesis. A c...

$191.5K
USD
Completed NON-SBIR/STTR RPGS
Biomaterial Scaffolds for Ex Vivo and In Situ CAR-T Cell Production
NATIONAL CANCER INSTITUTE North Carolina State University Raleigh United States 2021 – 2024

PROJECT SUMMARY Despite unprecedented clinical success of chimeric antigen receptor (CAR)-T cell therapy against tumors, widespread application is limited by lengthy and labor-inte...

$57.8K
USD
Completed NON-SBIR/STTR RPGS
Using Natural Language Processing and Crowdsourcing to Monitor and Evaluate Public Information and Communication Disparities about Colon Cancer Screening
NATIONAL CANCER INSTITUTE University of Utah United States 2021 – 2025

PROJECT SUMMARY Colorectal cancer (CRC) incidence and death rates are higher among Black Americans than non-Hispanic White Americans. While some CRC-related disparities have decrea...

$3.81M
USD